Search For "cova"
Approval to Covaxin for children aged between 2-18 years awaited after eva
Updated : 4 years, 5 months ago IST
New Delhi [India], October 12 (ANI): After the evaluation of data Covaxin is yet to get approval by the Drugs Controller General of India (DCGI) for children between 2-18 years old, according to official sources.
Read More
COVID-19: Subject Expert Committee gave recommendation to DCGI to use Cova
Updated : 4 years, 5 months ago IST
New Delhi [India], October 12 (ANI): Subject Expert Committee (SEC) has given a recommendation to the Drugs Controller General of India (DCGI) for the use of Bharat Biotech's COVID-19 vaccine Covaxin for the beneficiaries aged between 2-18 years, the official sources said.
Read More
Covaxin trials on children show similar results as on adults, says expert
Updated : 4 years, 5 months ago IST
New Delhi [India], October 11 (ANI): As India's largest COVID-19 vaccination drive is underway, an AIIMS professor has claimed that the latest trials show that the safety and immunogenicity of India's indigenous COVID-19 vaccine--Covaxin--are almost the same in children, as adults above 1
Read More
India-UK travel restrictions row to end soon, hopes MEA
Updated : 4 years, 5 months ago IST
New Delhi [India], October 7 (ANI): The Ministry of External Affairs on Thursday said that there can be an early solution to the India-UK travel restrictions row.
Read More
WHO decision on Covaxin nod extended to next week
Updated : 4 years, 5 months ago IST
Geneva [Switzerland], October 5 (ANI): World Health Organisation (WHO) has extended giving the emergency use authorization for Hyderabad-based Bharat Biotech's COVID-19 vaccine Covaxin to next week.
Read More
Germany will take next step after WHO's approval of Covaxin, says envoy Li
Updated : 4 years, 5 months ago IST
New Delhi [India], October 3 (ANI): German Ambassador to India, Walter J Lindner on Sunday asserted that his country would take the next step regarding Covaxin as soon as World Health Organization (WHO) would recognise Bharat Biotech's COVID vaccine to treat the virus.
Read More
Vaccination of children only way to get rid of COVID pandemic: AIIMS Direc
Updated : 4 years, 5 months ago IST
New Delhi [India], October 2 (ANI): Children between 12 to 18 years of age will be vaccinated against COVID-19 very soon, said Dr Randeep Guleria, Director of All Indian Institute of Medical Sciences (AIIMS), Delhi.
Read More
WHO to give approval to Covaxin this month, say top health experts
Updated : 4 years, 5 months ago IST
New Delhi [India], October 2 (ANI): The decision on Bharat Biotech's Covid-19 vaccine, Covaxin Emergency Use Listing (EUL) by the World Health Organisation (WHO) is expected in October, informed the top health experts in the country on Saturday.
Read More
AIIMS Delhi Director hopes for early approval of COVID-19 vaccine Covaxin
Updated : 4 years, 5 months ago IST
New Delhi [India], October 1 (ANI): With the data and studies regarding COVID-19 vaccine Covaxin submitted to the World Health Organization, All India Institute of Medical Sciences (AIIMS) Delhi Director Randeep Guleria is hopeful that the authorisation for emergency use listing to the vacci
Read More
Talks of booster Covid vaccine dose in India not pertinent at present, say
Updated : 4 years, 5 months ago IST
New Delhi [India], September 30 (ANI): Underlining that more than 95 per cent of the antibodies persist for over a year among COVID-19 vaccinated persons as per some studies, the Union Health Ministry on Thursday cleared the air on booster dose, saying talks in this regard are not pertinent
Read More
India to procure 27-28 crore COVID-19 vaccine doses in October: Sources
Updated : 4 years, 5 months ago IST
New Delhi [India], September 30 (ANI): India would have 27-28 crore COVID-19 vaccine doses of Serum Institute of India's Covishield and Bharat Biotech's Covaxin in the month of October, said government sources.
Read More
WHO to decide on Bharat Biotech's Covaxin emergency usage in October
Updated : 4 years, 5 months ago IST
New Delhi [India] September 30 (ANI): The World Health Organisation (WHO) on Wednesday informed that the final decision on Bharat Biotech's submission on emergency use listing (EUL) for its Covaxin COVID-19 vaccine will be made in October 2021.
Read More